Chesnara Plc: Fourth acquisition in two years
12 November 2026
Maze Therapeutics, Inc. (NASDAQ: MAZE) has captured the attention of investors with its promising developments in the biotechnology sector. As a clinical-stage biopharmaceutical company, Maze focuses..
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is capturing the attention of investors with its substantial potential upside of 114.62%, according to recent analyst ratings. As a clinical-stage..
Trevi Therapeutics, Inc. (NASDAQ: TRVI), a pioneering clinical-stage biopharmaceutical company, has captured the attention of investors with its promising drug pipeline and significant potential upside. As..
Replimune Group, Inc. (NASDAQ: REPL) is garnering attention in the biotechnology industry with its innovative approach to cancer treatment. As a clinical-stage company, Replimune is focused..
HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the healthcare information services sector, presents an intriguing opportunity for investors seeking growth in the healthcare technology space...
Investors with an eye on the biotechnology sector may find Precigen, Inc. (NASDAQ: PGEN) an intriguing prospect, given its focus on innovative gene and cell therapies...
Investors with a keen interest in the biotechnology sector should take note of Mind Medicine (MindMed) Inc. (MNMD), a company positioned at the forefront of developing..
ArriVent BioPharma, Inc. (NASDAQ: AVBP) has recently caught the attention of investors with its promising pipeline in the biotechnology sector. As a clinical-stage biopharmaceutical company, ArriVent..
Beta Bionics, Inc. (BBNX), a prominent player in the healthcare sector, is emerging as a formidable force in the medical device industry. With a current market..
SIGA Technologies Inc. (NASDAQ: SIGA) might not be a household name in the vast landscape of healthcare, but this commercial-stage pharmaceutical company is making significant strides..
Investors seeking opportunities in the healthcare sector may want to turn their attention to Evolus, Inc. (NASDAQ: EOLS), a specialty and generic drug manufacturer that has..
For investors seeking exposure to the burgeoning field of psychedelic therapeutics, COMPASS Pathways Plc (NASDAQ: CMPS) presents a compelling opportunity. As a healthcare company specializing in..
Organogenesis Holdings Inc. (NASDAQ: ORGO) presents an intriguing opportunity for investors seeking exposure to the healthcare sector, specifically within the niche of regenerative medicine. With a..
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is quickly becoming a notable player in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. This..
Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company focusing on innovative treatments for infectious diseases, is capturing investor interest with its compelling potential upside of..
Investors in the biotechnology sector may find CorMedix Inc. (NASDAQ: CRMD) to be an intriguing prospect, particularly given the impressive potential upside of 101.86% as highlighted..
Semler Scientific, Inc. (NASDAQ: SMLR), a U.S.-based company specializing in medical devices, is attracting significant investor attention due to its remarkable potential upside of 258.65%. Despite..
Akebia Therapeutics, Inc. (NASDAQ: AKBA), a prominent player in the healthcare sector specializing in drug manufacturing for kidney diseases, presents a compelling investment opportunity with significant..
Zenas BioPharma, Inc. (ZBIO), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising pipeline of immunology-based therapies and a current analyst..
Investors with an eye on the burgeoning field of cancer diagnostics may want to consider Personalis, Inc. (NASDAQ: PSNL), a significant player in the healthcare sector’s..
